Stocks in Focus

KOLMAR KOREA Jumps Over 20% on Surprise Second-Quarter Earnings [Stock Spotlight]

PARK MIN
2026-08-12 10:00:34
[Edaily Reporter PARK MIN ] KOLMAR KOREA(161890)is surging by more than 20% in early trading on the 12th after announcing record-breaking quarterly earnings for the second quarter of this year.

According to MP Doctor, as of 9:56 a.m. today, KOLMAR KOREA is trading at 132,000 won, up 22.34% from the previous close. This is attributed to buying pressure driven by the company’s second-quarter “earnings surprise.”

Today, KOLMAR KOREA announced that its consolidated operating profit for the second quarter rose 50.17% year-over-year to 110,341 million won, while revenue increased 17.85% to 861,277 million won. Both revenue and operating profit represent all-time highs on a quarterly basis.

The expansion of global sales channels for indie brands, driven by the K-Beauty boom, is cited as the reason behind KOLMAR KOREA’s strong performance. A KOLMAR KOREA official stated, “Orders increased, particularly for skincare and suncare products, due to the expansion of indie brands’ global presence and the peak season effect for suncare products,” adding, “With the continued launch of new products by our global clients, we recorded our highest-ever quarterly results.”

Economy

Corporation

IT·Science

Economy

KBI METAL CO., LTD., Which Has Expanded Its Wire and Cable Business, Posts Record Cumulative Operating Profit… but Slows Down in the Third Quarter

KBI METAL CO., LTD.’s Eumseong Plant Office Building. (Photo courtesy of KBI Group) KBI METAL CO., LTD. posted its highest-ever cumulative operating profit for the first three quarters of this year,…
2026-11-13 22:11:12

Corporation

[Exclusive] Lotte Group to Announce Regular Personnel Shuffle on the 16th… All Eyes on Whether President Shin Yu-yeol Will Be Promoted

Lotte Group will hold board meetings for its affiliates as early as the 16th to carry out its regular executive reshuffle. Following last year’s replacement of 20 chief executive officers (CEOs), all …
2026-11-13 22:52:44

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02